In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

Britain will study whether the use of Eli Lilly’s weight loss drug can get people back into work and help tackle the high ...

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

In Mounjaro it’s tirzepatide. I’d noticed that my weight had been creeping up, and I can’t deny that a passion for French ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

The plans to use give unemployed overweight people Mounjaro were introduced by Wes Streeting earlier this week.

Weight-loss jabs could be used to help unemployed people get back to work, in a plan under consideration by Wes Streeting. Writing in The Telegraph, the health secretary said obesity was placing a ...